ReviewCells2022

LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo.

Rayan Berabez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.